BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38514346)

  • 1. [The association between baseline TPOAb and/or TgAb positivity and thyroid immune-related adverse events in patients with malignancies following treatment with immune checkpoint inhibitors].
    Gao Y; Ye T; Wu LG; Xu Y; Wang X; Cheng XQ; Zhang YL; Wang YY; Fan XR; Zhao HT; Liu H; Chai XF; Zhang L; Wang MZ; Li NS; Lian XL
    Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(12):963-969. PubMed ID: 38514346
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of Thyroid Dysfunction in PD-1 Blockade Is Stratified by the Pattern of TgAb and TPOAb Positivity at Baseline.
    Zhou X; Iwama S; Kobayashi T; Ando M; Arima H
    J Clin Endocrinol Metab; 2023 Sep; 108(10):e1056-e1062. PubMed ID: 37084392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Antithyroid Antibodies in Checkpoint Inhibitor-Associated Thyroid Immune-Related Adverse Events.
    Muir CA; Wood CCG; Clifton-Bligh RJ; Long GV; Scolyer RA; Carlino MS; Menzies AM; Tsang VHM
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1843-e1849. PubMed ID: 35104870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in TgAb and TPOAb titers are greater in thyrotoxicosis than isolated hypothyroidism induced by PD-1 blockade.
    Yamagami A; Iwama S; Kobayashi T; Zhou X; Yasuda Y; Okuji T; Ito M; Izuchi T; Ando M; Onoue T; Miyata T; Sugiyama M; Hagiwara D; Suga H; Banno R; Arima H
    Endocr J; 2024 Apr; ():. PubMed ID: 38599854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective study.
    Wu L; Xu Y; Wang X; Cheng X; Zhang Y; Wang Y; Fan X; Zhao H; Liu H; Chai X; Zhang L; Wang M; Li N; Pan H; Lian X
    Endocrine; 2023 Jul; 81(1):123-133. PubMed ID: 36867366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy.
    Luongo C; Morra R; Gambale C; Porcelli T; Sessa F; Matano E; Damiano V; Klain M; Schlumberger M; Salvatore D
    J Endocrinol Invest; 2021 Sep; 44(9):1927-1933. PubMed ID: 33576954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
    Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Thyroperoxidase Antibody and Thyroglobulin Antibody on Maternal and Neonatal Outcomes in Pregnant Women.
    Wang L; Tang Y; Yuan Y; Yu L; Jin B; Xia J; Yuan Q
    Horm Metab Res; 2022 Feb; 54(2):76-83. PubMed ID: 35130568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis.
    Tomisti L; Urbani C; Rossi G; Latrofa F; Sardella C; Manetti L; Lupi I; Marcocci C; Bartalena L; Curzio O; Martino E; Bogazzi F
    J Endocrinol Invest; 2016 May; 39(5):585-91. PubMed ID: 26759156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs).
    Daban A; Gonnin C; Phan L; Saldmann A; Granier C; Lillo-Lelouet A; Le Beller C; Pouchot J; Weiss L; Tartour E; Fabre E; Medioni J; Oudard S; Vano YA; Dragon-Durey MA; Simonaggio A
    Oncoimmunology; 2023; 12(1):2204754. PubMed ID: 37187974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Presence of Serum TgAb Suggests Lower Risks for Glucose and Lipid Metabolic Disorders in Euthyroid General Population From a National Survey.
    Zhang J; Gao Y; Li Y; Teng D; Xue Y; Yan L; Yang J; Yang L; Yao Y; Ba J; Chen B; Du J; He L; Lai X; Teng X; Shi X; Li Y; Chi H; Liao E; Liu C; Liu L; Qin G; Qin Y; Quan H; Shi B; Sun H; Tang X; Tong N; Wang G; Zhang JA; Wang Y; Ye Z; Zhang Q; Zhang L; Zhu J; Zhu M; Teng W; Shan Z; Li J
    Front Endocrinol (Lausanne); 2020; 11():139. PubMed ID: 32256451
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical characteristics and risk factors of programmed death-1 inhibitors associated with thyroid gland injury].
    Gong WW; Zhou FY; Guo QH
    Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):176-181. PubMed ID: 36740408
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism.
    Carlé A; Laurberg P; Knudsen N; Perrild H; Ovesen L; Rasmussen LB; Jorgensen T; Pedersen IB
    Autoimmunity; 2006 Sep; 39(6):497-503. PubMed ID: 17060029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Thyroid Peroxidase Antibodies and Thyroglobulin Antibodies with Thyroid Function in Pregnancy: An Individual Participant Data Meta-Analysis.
    Bliddal S; Derakhshan A; Xiao Y; Chen LM; Männistö T; Ashoor G; Tao F; Brown SJ; Vafeiadi M; Itoh S; Grineva EN; Taylor P; Ghafoor F; Vaidya B; Hattersley A; Mosso L; Oken E; Kishi R; Alexander EK; Maraka S; Huang K; Chaker L; Bassols J; Pirzada A; López-Bermejo A; Boucai L; Peeters RP; Pearce EN; Nelson SM; Chatzi L; Vrijkotte TG; Popova PV; Walsh JP; Nicolaides KH; Suvanto E; Lu X; Pop VJM; Forman JL; Korevaar TIM; Feldt-Rasmussen U
    Thyroid; 2022 Jul; 32(7):828-840. PubMed ID: 35596568
    [No Abstract]   [Full Text] [Related]  

  • 15. Positive Thyroid Peroxidase Antibody and Thyroglobulin Antibody are Associated With Better Clinicopathologic Features of Papillary Thyroid Cancer.
    Li L; Shan T; Sun X; Lv B; Chen B; Liu N; Zhang B; Hu S; Zeng Q; Turner AG; Sheng L
    Endocr Pract; 2021 Apr; 27(4):306-311. PubMed ID: 33645517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters.
    Kasagi K; Takahashi N; Inoue G; Honda T; Kawachi Y; Izumi Y
    Thyroid; 2009 Sep; 19(9):937-44. PubMed ID: 19678737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between iodine intake and thyroid autoantibodies: a cross-sectional study of 7073 early pregnant women in an iodine-adequate region.
    Sun J; Teng D; Li C; Peng S; Mao J; Wang W; Xie X; Fan C; Li C; Meng T; Zhang S; Du J; Gao Z; Shan Z; Teng W
    J Endocrinol Invest; 2020 Jan; 43(1):43-51. PubMed ID: 31264141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 Inhibitor-Induced Thyroiditis Is Associated with Better Overall Survival in Cancer Patients.
    Kotwal A; Kottschade L; Ryder M
    Thyroid; 2020 Feb; 30(2):177-184. PubMed ID: 31813343
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index.
    Pollack R; Ashash A; Cahn A; Rottenberg Y; Stern H; Dresner-Pollak R
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32668461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlations of serum TgAb and TPOAb and clinicopathological features of PTC in children and adolescents].
    Huang DM; Zhi JT; Zhang JM; Zheng XQ; Zhao JZ; Wei SF; Gao M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1418-1425. PubMed ID: 36707945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.